
Login
Who's Online
We have 106 guests and no members online
Statistics
- Users 5558
- Articles 748
- Articles View Hits 17586068
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- FDA approves Abeona’s ZEVASKYN gene therapy for RDEB - World Pharmaceutical Frontiers
Wed, 30 Apr 2025 14:27:2 GMT - Exosome Cell and Gene Therapy Market Deep Research with Forecast - openPR.com
Wed, 30 Apr 2025 13:55:0 GMT - Apertura Gene Therapy and Rett Syndrome Research Trust - GlobeNewswire
Wed, 30 Apr 2025 13:31:5 GMT - Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting - Yahoo Finance
Wed, 30 Apr 2025 13:30:0 GMT - Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting - PR Newswire
Wed, 30 Apr 2025 13:30:0 GMT - Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid - PR Newswire
Wed, 30 Apr 2025 13:30:0 GMT - Abeona prices rare cell disorder gene therapy at $3.1m - Pharmaphorum
Wed, 30 Apr 2025 12:20:0 GMT - Gene Therapy Research Roundup: Gene Circuits and Controlling Capsids With Machine Learning - themedicinemaker.com
Wed, 30 Apr 2025 10:24:1 GMT - Gene Therapy for Cardiovascular Disease Market Poised for Rapid - openPR.com
Wed, 30 Apr 2025 09:20:0 GMT - Gene Therapy: Expert Explains How It Can Help Deal With Critical Cases Of Haematology - OnlyMyHealth
Wed, 30 Apr 2025 07:22:5 GMT - MIT team designs gene circuits for tighter control in gene therapy study - drugdiscoverytrends.com
Wed, 30 Apr 2025 05:19:1 GMT - Asembia AXS25: Navigating Challenges in Cell and Gene Therapy - Pharmacy Times
Wed, 30 Apr 2025 02:56:1 GMT - Abeona's $3.1M gene therapy wins FDA nod for rare skin disease - FirstWord Pharma
Wed, 30 Apr 2025 02:43:1 GMT - Overcoming Barriers to Access in Cell and Gene Therapy | Asembia’s AXS25 Summit - Managed Healthcare Executive
Wed, 30 Apr 2025 01:20:2 GMT - FDA Approves Abeona Gene Therapy for Healing Wounds From Rare, Inherited Skin Disease - MedCity News
Wed, 30 Apr 2025 00:07:3 GMT